ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

RFPs Available

May 5, 2000

In Brief: Frozen Panels Available to Evaluate diagnostic Assays; Panel to Meet at Johns Hopkins April 22

March 15, 1985

DCT Board Okays Consideration Of New New Heavy Particle Therapy Studies

March 8, 1985

ASCO Recommends Discussing Pharmacological Prevention

July 26, 2013

Kulig Will Oversee Outcomes Research at NCCN

September 30, 2011

St. Vincent Of NYC Joins Funded CCOPS Spurr To Be Professor Emeritus; UCOG, Still Unfunded, Still Active

May 1, 1987